From Systems Understanding to Personalized Medicine: Lessons and Recommendations Based on a Multidisciplinary and Translational Analysis of COPD.
暂无分享,去创建一个
Jesper Tegnér | David Gomez-Cabrero | Josep Roca | Isaac Cano | J. Tegnér | J. Roca | D. Gómez-Cabrero | Isaac Cano
[1] Eric J Topol,et al. Individualized Medicine from Prewomb to Tomb , 2014, Cell.
[2] Josep Roca,et al. A systems biology approach reveals a link between systemic cytokines and skeletal muscle energy metabolism in a rodent smoking model and human COPD , 2014, Genome Medicine.
[3] Amanda H. Salanitro,et al. Risk prediction models for hospital readmission: a systematic review. , 2011, JAMA.
[4] B. Celli,et al. Comorbidities and risk of mortality in patients with chronic obstructive pulmonary disease. , 2012, American journal of respiratory and critical care medicine.
[5] David Gomez-Cabrero,et al. The COPD Knowledge Base: enabling data analysis and computational simulation in translational COPD research , 2014, Journal of Translational Medicine.
[6] D. Poole,et al. Muscle oxygen transport and utilization in heart failure: implications for exercise (in)tolerance. , 2012, American journal of physiology. Heart and circulatory physiology.
[7] R. Thomas,et al. Multistationarity, the basis of cell differentiation and memory. I. Structural conditions of multistationarity and other nontrivial behavior. , 2001, Chaos.
[8] L. Hood,et al. Systems medicine and integrated care to combat chronic noncommunicable diseases , 2011, Genome Medicine.
[9] S. Rennard,et al. COPD Heterogeneity: What This Will Mean in Practice , 2011, Respiratory Care.
[10] Lew McCreary,et al. Kaiser Permanente's innovation on the front lines. , 2010, Harvard business review.
[11] Andrew J. Bulpitt,et al. A Primer on Learning in Bayesian Networks for Computational Biology , 2007, PLoS Comput. Biol..
[12] Josep Roca,et al. Telemedicine enhances quality of forced spirometry in primary care , 2011, European Respiratory Journal.
[13] Tom Doel,et al. Computational modeling of the obstructive lung diseases asthma and COPD , 2014, Journal of Translational Medicine.
[14] Judy A. Shea,et al. Open Access in the Patient-Centered Medical Home: Lessons from the Veterans Health Administration , 2013, Journal of General Internal Medicine.
[15] A. Barabasi,et al. Uncovering disease-disease relationships through the incomplete interactome , 2015, Science.
[16] Edwin K Silverman,et al. Characterisation of COPD heterogeneity in the ECLIPSE cohort , 2010, Respiratory research.
[17] Jesper Tegnér,et al. Systems Medicine: from molecular features and models to the clinic in COPD , 2014, Journal of Translational Medicine.
[18] Kumiko Hattori,et al. A comparison of three multidimensional indices of COPD severity as predictors of future exacerbations , 2013, International journal of chronic obstructive pulmonary disease.
[19] Tudor I. Oprea,et al. Temporal disease trajectories condensed from population-wide registry data covering 6.2 million patients , 2014, Nature Communications.
[20] J Frank Wharam,et al. The promise and peril of healthcare forecasting. , 2012, The American journal of managed care.
[21] Luigi Ceccaroni,et al. Clinical Decision Support Systems (CDSS) for preventive management of COPD patients , 2014, Journal of Translational Medicine.
[22] A. Barabasi,et al. Systems biology and the future of medicine , 2011, Wiley interdisciplinary reviews. Systems biology and medicine.
[23] Judith Garcia-Aymerich,et al. Phenotypic Characterization and Course of Chronic Obstructive Pulmonary Disease in the PAC-COPD Study: Design and Methods , 2009 .
[24] Ulrike Held,et al. Expansion of the prognostic assessment of patients with chronic obstructive pulmonary disease: the updated BODE index and the ADO index , 2009, The Lancet.
[25] Gilles Clermont,et al. Computational disease modeling – fact or fiction? , 2009, BMC Systems Biology.
[26] Martin J. Aryee,et al. Epigenome-wide association data implicate DNA methylation as an intermediary of genetic risk in Rheumatoid Arthritis , 2013, Nature Biotechnology.
[27] Albert Alonso,et al. Integrated care services: lessons learned from the deployment of the NEXES project , 2015, International journal of integrated care.
[28] Krin A. Kay,et al. The implications of human metabolic network topology for disease comorbidity , 2008, Proceedings of the National Academy of Sciences.
[29] Ciro Casanova,et al. The progression of chronic obstructive pulmonary disease is heterogeneous: the experience of the BODE cohort. , 2011, American journal of respiratory and critical care medicine.
[30] Jesper Tegnér,et al. Chronic Obstructive Pulmonary Disease heterogeneity: challenges for health risk assessment, stratification and management , 2014, Journal of Translational Medicine.
[31] Josep Roca,et al. A Systems Biology Approach Identifies Molecular Networks Defining Skeletal Muscle Abnormalities in Chronic Obstructive Pulmonary Disease , 2011, PLoS Comput. Biol..
[32] Josep Roca,et al. Comparison of predictive risk modeling among 5 European regions in the ACT project , 2015 .
[33] A. Barabasi,et al. Network medicine : a network-based approach to human disease , 2010 .
[34] J. Tegnér,et al. Synergy-COPD: a systems approach for understanding and managing chronic diseases , 2014, Journal of Translational Medicine.
[35] Josep Roca,et al. Identification and prospective validation of clinically relevant chronic obstructive pulmonary disease (COPD) subtypes , 2010, Thorax.
[36] T. Mikkelsen,et al. The NIH Roadmap Epigenomics Mapping Consortium , 2010, Nature Biotechnology.
[37] Xu Chen,et al. Heterogeneity of chronic obstructive pulmonary disease: from phenotype to genotype , 2013, Frontiers of Medicine.
[38] Alan D. Lopez,et al. Measuring the global burden of disease. , 2013, The New England journal of medicine.
[39] S. Coughlin. Toward a road map for global -omics: a primer on -omic technologies. , 2014, American journal of epidemiology.
[40] Jesper Tegnér,et al. Accelerating Translational Research by Clinically Driven Development of an Informatics Platform–A Case Study , 2014, PloS one.
[41] Hiroaki Kitano,et al. The systems biology markup language (SBML): a medium for representation and exchange of biochemical network models , 2003, Bioinform..
[42] Peter J. Barnes,et al. Mechanisms of development of multimorbidity in the elderly , 2015, European Respiratory Journal.
[43] Thierry Troosters,et al. An official American Thoracic Society/European Respiratory Society statement: update on limb muscle dysfunction in chronic obstructive pulmonary disease. , 2014, American journal of respiratory and critical care medicine.
[44] P. J. Barnes,et al. Systemic manifestations and comorbidities of COPD , 2009, European Respiratory Journal.
[45] Charles Auffray,et al. Predictive, preventive, personalized and participatory medicine: back to the future , 2010, Genome Medicine.
[46] J. Roca,et al. Effects and barriers to deployment of telehealth wellness programs for chronic patients across 3 European countries. , 2014, Respiratory medicine.
[47] K VanHentenryck. Health Level Seven. Shedding light on HL7's Version 2.3 Standard. , 1997 .
[48] P. Calverley,et al. The ABCD of GOLD made clear , 2013, European Respiratory Journal.
[49] Charles Auffray,et al. Participatory medicine: a driving force for revolutionizing healthcare , 2013, Genome Medicine.
[50] Klasien Horstman,et al. European practices of genetic information and insurance: lessons for the Genetic Information Nondiscrimination Act. , 2008, JAMA.
[51] Albert Alonso,et al. An adaptive case management system to support integrated care services: Lessons learned from the NEXES project , 2015, J. Biomed. Informatics.
[52] Niels H Chavannes,et al. Derivation and validation of a composite index of severity in chronic obstructive pulmonary disease: the DOSE Index. , 2009, American journal of respiratory and critical care medicine.
[53] Gj Ger Maas,et al. The construction sector as strategic contributor to the European Innovation Partnership on Active and Healthy Ageing (EIP-AHA) , 2014 .
[54] Edwin K Silverman,et al. Network medicine approaches to the genetics of complex diseases. , 2012, Discovery medicine.
[55] Courtney Crim,et al. Should we view chronic obstructive pulmonary disease differently after ECLIPSE? A clinical perspective from the study team. , 2014, American journal of respiratory and critical care medicine.
[56] F. Martinez,et al. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: GOLD executive summary. , 2007, American journal of respiratory and critical care medicine.
[57] Jesper Tegnér,et al. Biomedical research in a Digital Health Framework , 2014, Journal of Translational Medicine.
[58] Thierry Troosters,et al. An official American Thoracic Society/European Respiratory Society statement: research questions in COPD , 2015, European Respiratory Review.
[59] David Atkins,et al. The Veterans Affairs experience: comparative effectiveness research in a large health system. , 2010, Health affairs.
[60] Pere Caminal,et al. Clinical Decision Support System to Enhance Quality Control of Spirometry Using Information and Communication Technologies , 2014, JMIR medical informatics.
[61] M. Ashburner,et al. Gene Ontology: tool for the unification of biology , 2000, Nature Genetics.
[62] J. Epping-Jordan,et al. Innovative care for chronic conditions: building blocks for action , 2002 .
[63] Paul Enright,et al. Large-scale international validation of the ADO index in subjects with COPD: an individual subject data analysis of 10 cohorts , 2012, BMJ Open.